אנטקאביר סנדוז 1 מג ישראל - עברית - Ministry of Health

אנטקאביר סנדוז 1 מג

novartis israel ltd - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 1 mg - entecavir

הפסרה ישראל - עברית - Ministry of Health

הפסרה

glaxo smith kline (israel) ltd - adefovir dipivoxil - טבליה - adefovir dipivoxil 10 mg - adefovir dipivoxil - adefovir dipivoxil - hepsera is indicated for the treatment of chronic hepatitis b in adults with evidence of hepatitis b viral replication. reductions in viral replication and improvements in liver function have also been demonstrated in supportive studies in a limited number of chronic hepatitis b patients with genotypic evidence of lamivudine-resistance, including patients with compensated or decompensated liver disease and patients co-infected with hiv.

ברקלוד 1 מ"ג ישראל - עברית - Ministry of Health

ברקלוד 1 מ"ג

bristol, myers squibb (israel) limited - entecavir 1 mg - film coated tablets - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. this indication is based on clinical trial data in patients with hbeag positive and hbeag negative hbv infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis b.decompensated liver disease.

אוויפלרה ישראל - עברית - Ministry of Health

אוויפלרה

j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; rilpivirine as hydrochloride 25 mg; emtricitabine 200 mg - rilpivirine - rilpivirine - eviplera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is indicated for use as a complete regimen for the treatment of hiv-1 infection in antiretroviral treatment-naive adults. this indication is based on week 48 safety and efficacy analyses from 2 randomized, double-blind, active controlled, phase 3 trials in treatment-naive subjects comparing rilpivirine to efavirenz . the following points should be considered when initiating therapy with eviplera: -more rilpivirine-treated subjects with hiv-1 rna greater than 100,000 copies/ml at the start of therapy experienced virologic failure compared to subjects with hiv-1 rna less than 100,000 copies/ml at the start of therapy. -the observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the nnrti class compared to efavirenz . -more subjects treated with rilpivirine developed lamivudine/emtricitabine associated resistance compared to efavirenz. -eviplera is not recomme

אוויפלרה ישראל - עברית - Ministry of Health

אוויפלרה

j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; rilpivirine as hydrochloride 25 mg; emtricitabine 200 mg - rilpivirine - rilpivirine - eviplera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is indicated for use as a complete regimen for the treatment of hiv-1 infection in antiretroviral treatment-naive adults. this indication is based on week 48 safety and efficacy analyses from 2 randomized, double-blind, active controlled, phase 3 trials in treatment-naive subjects comparing rilpivirine to efavirenz . the following points should be considered when initiating therapy with eviplera: -more rilpivirine-treated subjects with hiv-1 rna greater than 100,000 copies/ml at the start of therapy experienced virologic failure compared to subjects with hiv-1 rna less than 100,000 copies/ml at the start of therapy. -the observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the nnrti class compared to efavirenz . -more subjects treated with rilpivirine developed lamivudine/emtricitabine associated resistance compared to efavirenz. -eviplera is not recomme

אנטקאביר טבע  0.5 מג ישראל - עברית - Ministry of Health

אנטקאביר טבע 0.5 מג

teva israel ltd - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 0.5 mg - entecavir

אנטקאביר טבע  1 מג ישראל - עברית - Ministry of Health

אנטקאביר טבע 1 מג

teva israel ltd - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 1 mg - entecavir

ביקטארווי ישראל - עברית - Ministry of Health

ביקטארווי

gilead sciences israel ltd - bictegravir as sodium; emtricitabine; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; bictegravir as sodium 50 mg - emtricitabine, tenofovir alafenamide and bictegravir

ביקטארווי ישראל - עברית - Ministry of Health

ביקטארווי

gilead sciences israel ltd - bictegravir as sodium; emtricitabine; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; bictegravir as sodium 50 mg - emtricitabine, tenofovir alafenamide and bictegravir

אנטקאביר אס.קיי. 0.5 מג ישראל - עברית - Ministry of Health

אנטקאביר אס.קיי. 0.5 מג

k.s.kim international (sk- pharma) ltd., israel - entecavir as monohydrate - טבליות מצופות פילם - entecavir as monohydrate 0.5 mg - entecavir